PAVmed Inc. Common Stock (PAVM) is a publicly traded Healthcare sector company. As of May 21, 2026, PAVM trades at $5.98 with a market cap of $45.16M and a P/E ratio of -1.08. PAVM moved -4.84% today. Year to date, PAVM is -17.01%; over the trailing twelve months it is -67.72%. Its 52-week range spans $6.00 to $43.44. Analyst consensus is buy with an average price target of $40.50. Rallies surfaces PAVM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PAVmed Q1 Loss of $4.42 EPS, $22K Revenue and $6.5M Cash: PAVmed reported a Q1 GAAP loss of $4.42 per diluted share and minimal revenue of $22,000, up from $8,000 a year earlier. The company ended March with $6.5 million in cash, a 2.02 current ratio, but continues to face recurring losses and going-concern uncertainty.
| Metric | Value |
|---|---|
| Price | $5.98 |
| Market Cap | $45.16M |
| P/E Ratio | -1.08 |
| EPS | $-5.63 |
| Dividend Yield | 0.00% |
| 52-Week High | $43.44 |
| 52-Week Low | $6.00 |
| Volume | 5 |
| Avg Volume | 0 |
| Revenue (TTM) | $71.00K |
| Net Income | $-2.47M |
| Gross Margin | -207.04% |
2 analysts cover PAVM: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $40.50.